EUVIMEDEUVIMED entdecken
Crossref

Microneedle patch capable of dual drug release for drug delivery to brain tumors

Robab Mousavi, Madjid Soltani, Mohammad Souri

Drug Delivery and Translational Research · 2025-05 · 15 (5) · 1567-1594

DOI: 10.1007/s13346-024-01696-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 26.08.2024. Verfasst von Robab Mousavi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran. Hauptthemen laut MEDLINE: Brain Neoplasms, Doxorubicin, Drug Delivery Systems, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary brain tumors are mostly managed using surgical resection procedures. Nevertheless, in certain cases, a thin layer of tumors may remain outside of the resection process due to the possibility of permanent injury; these residual tumors expose patients to the risk of tumor recurrence. This study has introduced the use of microneedle patches implanted after surgery with a dual-release mechanism for the administration of doxorubicin. The proposed patches possess the capability to administer drugs directly to the residual tumors and initiate chemotherapy immediately following surgical procedures. Three-dimensional simulation of drug delivery to residual tumors in the brain has been performed based on a finite element method. The impact of four important parameters on drug delivery has been investigated, involving the fraction of drug released in the burst phase, the density of microneedles on the patch, the length of microneedles, and the microvascular density of the tumor. The simulation findings indicate that lowering the fraction of drug released in the initial burst phase reduces the maximum average concentration, but the sustained release that continues for a longer period, increasing the bioavailability of free drug. However, the area under curve (AUC) for different release rates remains unchanged due to the fact that an identical dose of drug is supplied in each instance. By increasing the density of microneedles on the patch, concentration accumulation is provided over an extensive region of tumor, which in turn induces more cancer cell death. A comparative analysis of various lengths reveals that longer microneedles facilitate profound penetration into the tumor layers and present better therapeutic response due to extensive area of the tumor which is exposure to chemotherapeutic drugs. Furthermore, high microvascular density, as a characteristic of the tumor microenvironment, is shown to have a significant impact on the blood microvessels drainage of drugs and consequently lower therapeutic response outcome. Our approach offers a computational framework for creating localized drug delivery systems and addressing the challenges related to residual brain tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsDoxorubicinDrug Delivery SystemsAntibiotics, AntineoplasticNeedlesHumansDrug LiberationMicroinjections

Stichwörter der Autor:innen

Dual releaseLocal deliveryMathematical modelMicroneedleResidual brain tumors

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
  • Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran. msoltani@uwaterloo.ca.
  • Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, Canada. msoltani@uwaterloo.ca.
  • Centre for Biotechnology and Bioengineering (CBB), University of Waterloo, Waterloo, Canada. msoltani@uwaterloo.ca.
  • Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada. msoltani@uwaterloo.ca.
  • Centre for Sustainable Business, International Business University, Toronto, Canada. msoltani@uwaterloo.ca.

Zitieren

APA

Mousavi, R., Soltani, M., & Souri, M. (2025). Microneedle patch capable of dual drug release for drug delivery to brain tumors. Drug Delivery and Translational Research, 15(5), 1567-1594. https://doi.org/10.1007/s13346-024-01696-6

Vancouver

Mousavi R, Soltani M, Souri M. Microneedle patch capable of dual drug release for drug delivery to brain tumors. Drug Delivery and Translational Research. 2025;15(5):1567-1594. doi:10.1007/s13346-024-01696-6

BibTeX
@article{Mousavi2025,
  author = {Mousavi, Robab and Soltani, Madjid and Souri, Mohammad},
  title = {Microneedle patch capable of dual drug release for drug delivery to brain tumors},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {1567--1594},
  doi = {10.1007/s13346-024-01696-6}
}
Kostenlos starten →